Connect with us

News

Beyond ‘bikini medicine’: Can femtech help reframe the narrative around women’s health?

Published

on

From stigma and siloed systems to underinvestment and red tape, women face numerous barriers when it comes to accessing better care, but femtech founders and policy experts say digital innovation could offer a path forward.

In a new report, a panel of global experts from the fields of health, femtech and law have called for digital innovation, life-course care, and the breaking down of outdated silos in medicine to address global gender health gaps. 

The group of experts, led by Kate Lancaster, CEO of The Royal College of Obstetricians and Gynaecologists, also agree that women’s health should be seen not as a subset of reproductive care, but as the broader ‘health of women’.

A significant number of chronic health conditions, including neurological disorders such as migraine and autoimmune diseases, are known to affect women more than men.

Yet globally, women continue to face disproportionately high rates of underdiagnosis, delayed treatment, and poorer outcomes. 

In the UK, which continues to have the widest gender health inequalities in the G20, women spend an average of nine years in poor health, 25 per cent more of their lives than men. 

The panel discussion has informed a three-series report, FemHealth Focus, commissioned by UK law firm Mills & Reeve, highlighting the role of technology and innovation in driving change, and the role that public healthcare systems like the NHS can play in supporting women’s health innovators.

In the second part of the report, published recently, experts highlighted that fragmented commissioning structures, siloed services, and the way women’s health is conceptualised are all obstacles to a more ‘joined-up’ approach that could help to deliver improved outcomes for women.

The global female healthtech market is growing at an annual rate of 16 per cent, and experts agree that digital technologies and AI have a ‘central role’ to play in ‘boosting efficiency’. 

Yet healthtech companies struggle to scale due to stigma, underfunding, and the weight of ‘NHS bureaucracy’. 

One panellist said it had taken “blood, sweat and tears” to secure a deal with a single NHS Trust. The challenge was not a ‘lack of willingness’, but the ‘weight of bureaucracy and segregated budgets’, they added. 

Many early-stage companies enter the market targeting consumers directly, with the hope of securing a future partnership within the NHS, but this often raises concerns about ‘equity and access’.

To address this, the panel called for stronger engagement in women’s health from corporates and insurers, with insurance still a relatively underdeveloped market in femtech.

Some panellists reported ‘growing interest’ in the corporate market, where employers are increasingly aware of the need to address women’s health as part of their recruitment and retention strategies.

At the same time, they say, greater health literacy and education are needed to break down barriers, particularly for startups seeking investment.

Some founders on the panel reported difficulty securing investment due to investor discomfort with women’s health-related topics.

Businesses in this sector are also disproportionately impacted by additional challenges, such as censorship on social platforms and bias in accessing financial services.

CensHERship, a campaign group working to end online censorship of women’s health content, found that many femtech companies not only faced barriers on social media and e-commerce platforms but had been refused bank accounts or were subjected to higher fees by banks and insurance providers, according to the report. 

“There remains a stigma attached to women’s health that not only impacts investment opportunities but also leads to a deprioritisation in health budgets and services, and in education,” the report states. 

NHS reform – an opportunity for the UK to lead the way in women’s health

The report comes at a pivotal moment for women’s health around the world, and just weeks after the UK Health Secretary unveiled his 10-Year Plan to reform the NHS, introducing shifts from hospital to community, sickness to prevention and analogue to digital. 

However, despite promises that the strategy will play a fundamental role in delivering the government’s commitment to women’s health, “never again being ignored”, the plan has been accused of “falling short” for women.

RCOG president Professor Ranee Thakar, said in a statement: “While the plan lays strong foundations, it falls short in pledging to eliminate the gender health gap that is costing women years of life and good health…

“[The] plan must mark a move away from treating women’s health as a collection of niche issues towards offering women excellent, joined-up care across their life course, with investment in the women’s health workforce, Femtech and research.”

The 10-year Women’s Health Strategy, published in 2022, set out a six-point plan which promised to address these inequalities, including expanding women’s health hubs.

Women’s health hubs were intended to address fragmented systems and siloed services by bringing together primary care, diagnostics and specialist consultations under one roof, and were seen as ‘key areas’ for digital transformation, presenting a “major opportunity” for tech innovators.

But their impact has been limited so far, with only 14 of 42 Integrated Care Boards currently offering all core services. 

The prospect of NHS reform could present a major opportunity for the UK to address gaps in care – and position itself as a world-leader in women’s health – by adopting solutions that address their unique needs.

“What we need is government-backed sustainable funding, so companies can really grow,” Gayle Curry, partner at Mills & Reeve, commented. 

“At the same time, we need cross-sector collaboration to deliver joined-up and accessible services.

“There is a place for the NHS, there is a place for the private sector, and there’s a place for innovation. What we need to do is work together to be able to offer that.”

‘Thoughtful’ innovation based on the needs of ‘real women’

As a GP specialising in women’s health for over 20 years, Dr Nikki Kanani has witnessed the challenges preventing women from accessing better healthcare first hand, and is now designing solutions to deliver back into the system, as co-founder of Aneira Health.

Aneira combines virtual and in-person support with AI and clinical expertise to offer personalised, tech-enabled plans for women throughout their lifespan. 

“[Women] are often treated in silos, and dismissed and deprioritised,” Dr Kanani told Femtech World.

“If a woman has to keep explaining her story and moving around the system to find the next bit of her care, that system has failed her.”

While the NHS has typically been “risk-averse” when it comes to partnering with innovators in the femtech sector, the 10-Year plan could well see more public-private collaboration, which Dr Kanani says would be a “huge opportunity” to build ethical, evidence-based tools based on the needs of real women. 

“We’ve got this boom in femtech, with hundreds of different point solutions, but without integration regulation… none of those will deliver their promises,” she said.

“There is a nod in the 10-year plan to public private partnerships, and if we can use those to build ethical evidence-based tools rooted in women’s real needs, that’s a huge opportunity to stop forcing women to fit into system that wasn’t designed for them, but instead build a system that is designed around women’s bodies, experiences and lives.”

But while advanced technology can play an important part in bridging some of these gaps, inequalities won’t be addressed by innovation alone; it will take ‘system-wide’ change.

“Digital can be empowering, but only when it’s inclusive and thoughtful,” Dr Kanani says.

“We’ve noticed that as we’ve built our organisation that there needs to be a power shift, from the centre to power-sharing with communities, so women are co-designers of care.

“Health equity for women, particularly those from minoritised, marginalised and underserved communities, won’t be achieved through strategy alone. We need a really deep, system-wide culture shift.”

The latest FemHealth report is both a call to action and a blueprint for change. 

Many solutions which could help address the gender health gap already exist, but to see real results, developers and policymakers must reimagine how care is designed in line with women’s real needs.

As Professor Dame Lesley Regan, Women’s Health Ambassador for England, Chair Wellbeing of Women, and Professor of Obstetrics and Gynaecology at Imperial College London, who contributed to the report, puts it: “Women make up 51 per cent of the UK population, undertake 68 per cent of all unpaid caring roles in society and are responsible for 80 per cent of all household health decisions.

“Optimising their health is far from being a niche concern; it is a national imperative.”

Wellness

WHO launches AI tool for reproductive health information

Published

on

The World Health Organization (WHO) has launched an AI tool in beta to help policymakers, experts and healthcare professionals access sexual and reproductive health information faster.

Called ChatHRP, the tool was created by WHO’s Human Reproduction Programme and draws only on verified research and guidance collected by HRP and WHO.

It uses natural language processing and retrieval-augmented generation to produce referenced content and cut the time spent searching through documents across different platforms and databases.

WHO said ChatHRP also has multilingual capabilities and low-bandwidth functionality to support use in a wide range of settings.

The beta-testing phase is aimed at a broad professional audience, including policymakers, healthcare workers, researchers and civil society groups.

WHO said the tool can help users quickly access up-to-date evidence, find sources for academic work and verify information on sexual and reproductive health and rights.

Examples of questions it can answer include the latest violence against women data in Oceania for women aged 15 to 49, recommendations on managing diabetes during pregnancy, and whether PrEP and contraception can be used at the same time. PrEP is medicine used to reduce the risk of getting HIV.

WHO added that the system will be updated regularly as new HRP materials are published and includes a feedback loop so users can flag gaps in the information provided.

The launch comes amid wider concern about misinformation in sexual and reproductive health.

A 2025 scoping review found that misinformation in digital spaces is a systemic issue that can undermine human rights, reinforce discriminatory social norms and exclude marginalised voices.

The review also said misinformation can affect health systems by shaping provider knowledge and practice, disrupting service delivery and creating barriers to equitable care.

WHO said ChatHRP is intended to give users streamlined access to reliable information as a counter to “algorithms, opinions, or misinformation”.

Continue Reading

Wellness

Women’s HealthX unveils Northwell Health, Corewell Health, Biogen & more to headline Chronic Disease stage

Published

on

Women’s HealthX has announced its lineup of healthcare trailblazers speaking on Chronic Disease Management, alongside other specialisations including Fertility, Sexual Health, Maternity, Menopause and Cognitive Health, taking a holistic approach to women’s health.

It will bring together 750+ leaders across pharma, health systems, and innovation to address one of the most urgent and underexamined challenges in healthcare; the sex difference gap in data and evidence.

Since cardiovascular disease remains the leading cause of death among women globally, and autoimmune and neurological conditions affect women at significantly higher rates, Women’s HealthX will home in on chronic disease management with 17+ sessions spotlighting case studies and lessons learned.

The Chronic Disease Management Stage at Women’s HealthX responds directly to this gap, convening senior decision makers and innovators to explore how sex specific science, digital health, and new care models can reshape outcomes for women.

Attending pharma & healthcare organisations include:

  • Tracy Sims, Executive Director, Cardiometabolic Health, Eli Lilly
  • Adrian Kielhorn, Senior Director, Global Head HEOR Neurology, Alexion Pharmaceuticals
  • Lauren Powell, Head of Health Equity and Clinical Innovation, Biogen
  • Amy Kao, SVP, Head of Neuroscience and Immunology Research, EMD Serono
  • Stella Vnook, Executive Chair and CEO, Kaida Biopharma
  • Amanda Borsky, Director, Clinical Research, Northwell Health
  • Lacey McIntosh, Division Chief, Oncologic and Molecular Imaging, UMass Memorial Medical Center
  • Nicole Turck, Vice President Operations, Women’s Health, Corewell Health
  • Mette Dyhrberg, CEO, Autoimmune Registry
  • Lyn Agostinelli, Principal Consultant, Halloran Consulting Group

Sessions addressing the real gaps in women’s chronic care

The agenda features a series of high impact sessions tackling the structural and scientific gaps in women’s health:

  • Improving outcomes in obesity through evidence based person centered care: Eli Lilly
  • Tackling sex based health inequities by breaking down barriers and bias: Alexion Pharmaceuticals
  • Close the health equity gap in women’s health by improving how autoimmune diseases are diagnosed, treated and managed: Autoimmune Registry
  • How a GYN only care model is driving faster access to gynecological care: Corewell Health
  • Transforming early detection in ovarian cancer: new pathways to accuracy, safety, and better outcomes: UMass Memorial Medical Center

Panel discussions include:

  • Why chronic disease looks different in women and why health systems haven’t adapted: Biogen, Kaida Biopharma, EMD Serono
  • How can we better engage with our customers: Northwell Health, Halloran Consulting Group

Health equity starts here. REGISTER YOUR PLACE

Why This Matters Now

Women’s HealthX positions chronic disease not just as a clinical challenge, but as a critical frontier for innovation, investment, and system redesign.

From AI powered monitoring and digital therapeutics to real world data and integrated care pathways, the stage highlights where meaningful progress is already being made and where the biggest opportunities lie.

For the FemTech ecosystem, this represents a pivotal moment: aligning technology, clinical insight, and commercial strategy to finally close the long standing data and care gaps in women’s health.

About Women’s HealthX

Women’s HealthX is where the transformation of women’s health begins at its true foundation: data, science, and evidence.

It’s the leading event dedicated to closing the sex difference data gap and accelerating breakthroughs through science driven, real world case studies.

Taking place on December 3 to 4, 2026 in Boston, USA, the exhibition will bring together more than 750 healthcare leaders, including clinicians, payers, employers, investors, and policymakers.

Seven different stages with 150+ expert speakers taking an holistic approach to women’s health. From fertility, maternity, sexual health, cognitive health, menopause and chronic disease, we address care at every stage of a woman’s life.

Continue Reading

Menopause

AI maps how reproductive organs age differently during menopause

Published

on

An AI atlas has mapped how reproductive organs age through menopause, with the ovaries, vagina and uterus changing on different timelines.

To better understand how this process affects health, researchers at the Barcelona Supercomputing Center developed what they describe as the first large-scale atlas of female reproductive system ageing, using artificial intelligence.

The team combined 1,112 tissue images from 659 samples, covering 304 women aged 20 to 70, with gene expression data from thousands of genes.

This allowed them to reconstruct how seven key reproductive organs, including the uterus, ovary, vagina, cervix, breast and fallopian tubes, age over time.

The study used the supercomputing power of MareNostrum 5 together with advanced image-recognition methods to process the data.

Using deep learning techniques, the researchers detected visible tissue changes as well as the underlying molecular processes linked to ageing in each organ.

The result was a detailed, organ-by-organ map of the reproductive system’s ageing process.

The researchers found that not all organs age in the same way or at the same speed. The ovaries and vagina showed a more gradual ageing process that begins even before menopause officially starts.

By contrast, the uterus appeared to undergo more sudden changes around the time of menopause.

Even within a single organ, different tissues aged at different rates. In the uterus, for example, the mucosa, its inner lining, and the muscular layer did not change in sync. These tissues also appeared to be particularly sensitive to the hormonal and biological shifts associated with menopause.

Marta Melé, leader of the transcriptomics and functional genomics group at BSC and director of the study, said: “Our results show that it acts as a turning point that profoundly reorganises other organs and tissues of the reproductive system, and allows us to identify the genes and molecular processes that could be behind these changes.”

Building on the finding that organs age according to different patterns, co-first author Laura Ventura said the research “paves the way for personalised medicine where treatments are tailored to a woman’s specific molecular profile and the specific tissues showing the most age-related distress.”

The study also identified molecular signals linked to reproductive ageing that can be detected in blood samples from more than 21,441 women.

These biomarkers could allow doctors to monitor the condition of reproductive organs in a non-invasive way, potentially helping to anticipate risks such as pelvic floor complications without the need for biopsies.

According to the researchers, this could lead to simpler and more accessible clinical tools for tracking women’s health over time.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.